StonvexLoading…
StonvexStonvexStonvexCore line items from AOS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-20 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.01B | $945.60M | $3.83B | $2.92B | $1.98B |
Operating Income | Not available | $161.80M | $728.60M | $565.60M | $390.20M |
Net Income | Not available | $118.00M | $546.20M | $420.80M | $288.80M |
EPS (Diluted) | $0.97 | $0.85 | $3.85 | $2.95 | $2.01 |
Total Assets | Not available | $3.65B | $3.14B | $3.17B | $3.25B |
Total Liabilities | Not available | $1.77B | $1.28B | $1.33B | $1.40B |
Cash & Equivalents | Not available | $185.20M | $174.50M | $152.70M | $177.90M |
Free Cash Flow OCF − CapEx | Not available | $118.90M | $546.00M | $380.50M | $139.90M |
Shares Outstanding | Not available | 139.17M | 141.91M | 142.58M | 143.44M |